Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Canaccord Genuity Initiates Coverage On Veracyte with Hold Rating, Announces Price Target of $40

Author: Benzinga Newsdesk | October 20, 2025 06:46am
Canaccord Genuity analyst Kyle Mikson initiates coverage on Veracyte (NASDAQ:VCYT) with a Hold rating and announces Price Target of $40.

Posted In: VCYT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist